Salt la conținut
Global sound
What's Next

What's Next

Antibody discovery with LabGenius' James Field

· 43 min

Note de episod

What do synthetic biology, machine learning and robotics have in common? James Field, CEO and founder of LabGenius, explains how his company is integrating bleeding-edge technologies from across these fields to discover the next-generation therapeutic antibodies. And change the way we approach drug discovery. Find out more about Labgenius here and follow them on LinkedIn Find Balderton Capital here and follow us on LinkedIn

Live, ultima oră: 9.223 melodii pe 3.675 posturi din 123 țări

Descoperă lumea prin radio

Mai multe moduri de a descoperi (7)

Ai auzit ceva frumos? Salvează-l sau deschide-l direct în Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
ROCK IN FRENCHContinuă să asculți